Rhabdomyosarcoma is a rare soft-tissue cancer. It can occur in many places in the body, but is often found in the head and neck, especially around the eyes. Rhabdomyosarcomas are most common in children. Certain inherited conditions increase the risk of this disease, including neurofibromatosis type 1 (NF1).
Johns Hopkins Hospital has earned the top spot in US News News & World Report's annual rankings of American hospitals — for the 21st year in a row. Johns Hopkins Neurology and Neurosurgery is also ranked #1 in the nation.
Chordoma: Drug screening starts to find new treatment for rare bone cancer
The Chordoma Foundation has awarded a $200,000 grant to Dr. Gary Gallia, a skull-base neurosurgeon and cancer biologist at Johns Hopkins. Gallia’s focus is on developing new therapies for brain and skull-based tumors. His lab has a long record of studying mouse models of brain tumors and he has developed a xenograft mouse model to study chordoma.
The Johns Hopkins Comprehensive Brain Tumor Center is a National Cancer Institute (NCI) designated Comprehensive Cancer Center.
The Hunt for a Brain Tumor Vaccine
Connect with Johns Hopkins Medicine
Subscribe to Johns Hopkins Medicine News
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts
